In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novian Health Raises $11 Million Series A; Ramps Up Studies Of Breast Cancer Laser Ablation

Executive Summary

Novian Health Inc. will use its recent $11 million Series A round to kickstart multicenter clinical trials on its Novilase Interstitial Laser Therapy for ablating early-stage breast cancer.

Advertisement

Related Content

Market Intel: New Thermal Therapies Blaze Trail In Fast-Growing Cancer Ablation Market
The Evolving World Of Breast Cancer Management

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT035604

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel